CLBT affiliate files to sell 4,517 RSU shares

CLBT affiliate filed a Form 144 proposing the sale of 4,517 common shares originally issued as Restricted Stock Units on 02/20/2026.

Rhea-AI Filing Summary

CLBT affiliate filed a Form 144 proposing the sale of 4,517 common shares originally issued as Restricted Stock Units on 02/20/2026. The filer reported two recent dispositions in the past three months: 2,609 shares sold on 02/23/2026 for $34,334.44 and 1,165 shares sold on 02/12/2026 for $16,612.90.

Insights

Securities Compliance Attorney

Form 144 reports an affiliate sale plan for 4,517 RSU-derived shares and recent discrete sales.

The filing lists 4,517 common shares "to be sold" from Restricted Stock Units dated 02/20/2026. Two separate past dispositions are reported: 2,609 shares on 02/23/2026 and 1,165 shares on 02/12/2026, with cash amounts shown.

These entries are routine Section 16 resale notices; timing and method of future sales are not detailed here. Subsequent SEC filings may show executed trades or additional planned dispositions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CLBT's Form 144 disclose about planned sales?

The Form 144 states a proposed sale of 4,517 common shares issued as Restricted Stock Units on 02/20/2026. It records the intended sale quantity and the original issuance date for those RSUs.

How many shares did the reporting person sell in the past three months?

The filing reports two recent dispositions totaling 3,774 shares: 2,609 shares sold on 02/23/2026 and 1,165 shares sold on 02/12/2026. Each sale includes its cash amount.

What proceeds were reported for the recent sales in CLBT Form 144?

Proceeds shown are $34,334.44 for the 2,609-share sale on 02/23/2026 and $16,612.90 for the 1,165-share sale on 02/12/2026, as disclosed in the filing.

Were the securities to be sold by CLBT affiliated with an issuer grant?

Yes. The filing lists the securities "to be sold" as Restricted Stock Units issued by the company on 02/20/2026, with an aggregate quantity of 4,517 common shares.

Who is the reporting person listed on the Form 144 for CLBT?

The filing identifies David N. Gee with an address in Petah Tikva and reports his recent dispositions and the proposed sale of RSU-derived common shares on the noted dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 04:31 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001547134
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Cellebrite DI Ltd.
SEC File Number	001-40772
Address of Issuer	94 Shlomo Shmelzer Road Petah Tikva ISRAEL 4970602
Phone	972733948000
Name of Person for Whose Account the Securities are To Be Sold	DAVID N GEE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4517	53932.98	245282244	02/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/20/2026	Restricted Stock Units	Issuer			4517	02/20/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DAVID N GEE 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Common	02/23/2026	2609	34334.44
DAVID N GEE 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Common	02/12/2026	1165	16612.90

144: Remarks and Signature

Remarks
Date of Notice	02/24/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/18/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ David Gee
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)